Jingyi Li

age ~53

from Carlsbad, CA

Jingyi Li Phones & Addresses

  • 2292 Camino Robledo, Carlsbad, CA 92009 • 8582104418
  • Vista, CA
  • Palmetto Bay, FL
  • Albany, CA
  • Salt Lake City, UT
  • Simi Valley, CA

Work

  • Company:
    Onestop financial services, inc.
    Sep 2012
  • Position:
    Staff accountant

Education

  • School / High School:
    San Francisco State University- San Francisco, CA
    2008
  • Specialities:
    Bachelor of Science in Business Administration Focus on Accounting

Resumes

Jingyi Li Photo 1

Senior Research Scientist

view source
Location:
Carlsbad, CA
Industry:
Research
Work:
Genomatica
Senior Research Scientist

University of Miami Sep 2009 - Dec 2010
Postdoctoral Researcher

Uc Berkeley Sep 2006 - Aug 2009
Postdoctoral Researcher
Education:
Oregon State University
Doctorates, Doctor of Philosophy, Biotechnology, Philosophy
Skills:
Biotechnology
Molecular Biology
Biochemistry
Molecular Cloning
Protein Expression
Pcr
Cell Culture
Bioinformatics
Cell Biology
Microbiology
Assay Development
High Throughput Screening
Genetics
Rt Pcr
Qpcr
Science
Life Sciences
Polymerase Chain Reaction
Microscopy
Metabolic Engineering
Protein Purification
Dna Sequencing
Dna
Genomics
Crispr
Enzyme Evolution
Research
Languages:
English
Mandarin
Jingyi Li Photo 2

Jingyi Li

view source
Jingyi Li Photo 3

Jingyi Li

view source
Jingyi Li Photo 4

Jingyi Li

view source
Location:
Carlsbad, CA
Jingyi Li Photo 5

Jingyi Li Cupertino, CA

view source
Work:
OneStop Financial Services, Inc.

Sep 2012 to 2000
Staff Accountant
VITA
San Francisco, CA
Jan 2012 to Apr 2012
Volunteer Tax Preparer
San Francisco State University
San Francisco, CA
Oct 2011 to Dec 2011
Student Assistant
San Francisco State University
San Francisco, CA
Sep 2009 to Dec 2010
Chinese Tutor
Education:
San Francisco State University
San Francisco, CA
2008 to 2012
Bachelor of Science in Business Administration Focus on Accounting

Us Patents

  • Eukaryotic Organisms And Methods For Increasing The Availability Of Cytosolic Acetyl-Coa, And For Producing 1,3-Butanediol

    view source
  • US Patent:
    20130066035, Mar 14, 2013
  • Filed:
    Sep 7, 2012
  • Appl. No.:
    13/607527
  • Inventors:
    Anthony P. Burgard - Bellefonte PA, US
    Mark J. Burk - San Diego CA, US
    Robin E. Osterhout - San Diego CA, US
    Priti Pharkya - San Diego CA, US
    Jingyi Li - Carlsbad CA, US
  • Assignee:
    Genomatica, Inc. - San Diego CA
  • International Classification:
    C12N 1/19
    C12Q 1/32
    C08G 63/00
    C07C 31/20
    C08G 18/32
    C12N 1/15
    C12P 7/18
  • US Classification:
    528 85, 43525421, 4352542, 43525411, 4352543, 43525423, 4352549, 435 26, 435158, 4352568, 568852, 528271
  • Abstract:
    Provided herein are non-naturally occurring eukaryotic organisms that can be engineered to produce and increase the availability of cytosolic acetyl-CoA. Also provided herein are non-naturally occurring eukaryotic organisms having a 1,3-butanediol (1,3-BDO) pathway. and methods of using such organisms to produce 1,3-BDO.
  • Olivetol Synthase Variants And Methods For Production Of Olivetolic Acid And Its Analog Compounds

    view source
  • US Patent:
    20220177858, Jun 9, 2022
  • Filed:
    Apr 17, 2020
  • Appl. No.:
    17/604722
  • Inventors:
    - San Diego CA, US
    Russell Scott Komor - San Diego CA, US
    Jingyi Li - San Diego CA, US
  • International Classification:
    C12N 9/10
    C12N 15/52
    C12N 1/20
    C12P 7/22
  • Abstract:
    Described herein are non-natural olivetol synthase (OLS) variants, nucleic acids, engineered cells, method s for preparing cannabinoids, and compositions thereof. The non-natural olivetol OLS variants form desired cannabinoid precursor and products at increased rates, have higher affinity for pathway substrates, and/or byproducts are formed in lower amounts in their presence, as compared to wild type OLS. The OLS variants can be used to form linear polyketides, and can be expressed in an engineered cell having a pathway to form cannabinoids, which include CBGA, its analogs and derivatives. CBGA can be used for the preparation of cannabigerol (CBG), which can be used in therapeutic compositions.
  • Pim Kinase Inhibitor Compositions, Methods, And Uses Thereof

    view source
  • US Patent:
    20230094365, Mar 30, 2023
  • Filed:
    Apr 29, 2022
  • Appl. No.:
    17/733404
  • Inventors:
    - San Diego CA, US
    Brandon Chen - San Diego CA, US
    Jingyi Li - San Diego CA, US
    Shawn Bachan - San Diego CA, US
  • International Classification:
    C07D 471/22
    C07D 487/14
    C07D 487/22
  • Abstract:
    This invention relates to compounds and compositions useful as inhibitors of PIM kinases. Also provided are methods of synthesis and methods of use of PIM inhibitors in treating individuals suffering from cancerous malignancies.
  • Alcohol Dehydrogenase Variants

    view source
  • US Patent:
    20200354692, Nov 12, 2020
  • Filed:
    Feb 17, 2020
  • Appl. No.:
    16/792592
  • Inventors:
    - San Diego CA, US
    Michael Patrick Kuchinskas - San Diego CA, US
    Jingyi Li - San Diego CA, US
    Harish Nagarajan - San Diego CA, US
    Priti Pharkya - San Diego CA, US
  • International Classification:
    C12N 9/04
    C12P 7/24
    C12P 7/18
  • Abstract:
    Described herein are non-natural NAD-dependent alcohol dehydrogenases (ADHs) capable of at least two fold greater conversion of methanol or ethanol to formaldehyde or acetaldehyde, respectively, as compared to its unmodified counterpart. Nucleic acids encoding the non-natural alcohol dehydrogenases, as well as expression constructs including the nucleic acids, and engineered cells comprising the nucleic acids or expression constructs are described. Also described are engineered cells expressing a non-natural NAD-dependent alcohol dehydrogenase, optionally include one or more additional metabolic pathway transgene(s), methanol metabolic pathway genes, target product pathway genes, cell culture compositions including the cells, methods for promoting production of the target product or intermediate thereof from the cells, compositions including the target product or intermediate, and products made from the target product or intermediate.
  • Pim Kinase Inhibitor Compositions, Methods, And Uses Thereof

    view source
  • US Patent:
    20200331914, Oct 22, 2020
  • Filed:
    Nov 5, 2018
  • Appl. No.:
    16/761715
  • Inventors:
    - San Diego CA, US
    Brandon Chen - San Diego CA, US
    Jingyi Li - San Diego CA, US
    Shawn Bachan - San Diego CA, US
  • International Classification:
    C07D 471/22
    C07D 487/14
    C07D 487/22
  • Abstract:
    This application relates to compounds of formulae (I) and (II) and compositions thereof useful as inhibitors of PIM kinases. Also provided are methods of synthesis and methods of use of PIM inhibitors in treating individuals suffering from cancerous malignancies.
  • Methanol Dehydrogenase Fusion Proteins

    view source
  • US Patent:
    20190085303, Mar 21, 2019
  • Filed:
    Oct 27, 2016
  • Appl. No.:
    15/771973
  • Inventors:
    - San Diego CA, US
    Jingyi Li - San Diego CA, US
    Joseph R. Warner - San Diego CA, US
    Priti Pharkya - San Diego CA, US
  • International Classification:
    C12N 9/04
    C12N 9/88
    C12N 9/90
    C12N 9/10
    C12P 7/24
  • Abstract:
    Described herein are fusion proteins including methanol dehydrogenase (MeDH) and at least one other polypeptide such as 3-hexulose-6-phosphate dehydrogenase (HPS) or 6-phospho-3-hexuloisomerase (PHI), such as DHAS synthase or fructose-6-Phosphate aldolase or such as DHA synthase or DHA kinase. In a localized manner, the fusion protein can promote the conversion of methanol to formaldehyde and then to a ketose phosphate such as hexulose 6-phosphate or then to DHA and G3P. When expressed in cells, the fusion proteins can promote methanol uptake and rapid conversion to the ketose phosphate or to the DHA and D3P, which in turn can be used in a pathway for the production of a desired bioproduct. Beneficially, the rapid conversion to the ketose phosphate or to the DHA and G3P can avoid the undesirable accumulation of formaldehyde in the cell. Also described are engineered cells expressing the fusion protein, optionally include one or more additional metabolic pathway transgene(s), methanol metabolic pathway genes, target product pathway genes, cell culture compositions including the cells, methods for promoting production of the target product or intermediate thereof from the cells, compositions including the target product or intermediate, and products made from the target product or intermediate.
  • Eukaryotic Organisms And Methods For Increasing The Availability Of Cytosolic Acetyl-Coa, And For Producing 1,3-Butanediol

    view source
  • US Patent:
    20170247709, Aug 31, 2017
  • Filed:
    Oct 11, 2016
  • Appl. No.:
    15/290895
  • Inventors:
    - San Diego CA, US
    Mark J. BURK - San Diego CA, US
    Robin E. OSTERHOUT - San Diego CA, US
    Priti PHARKYA - San Diego CA, US
    Jingyi LI - Carlsbad CA, US
  • International Classification:
    C12N 15/52
    C12P 7/18
    C12N 1/20
    C12N 1/16
    C12N 1/14
  • Abstract:
    Provided herein are non-naturally occurring eukaryotic organisms that can be engineered to produce and increase the availability of cytosolic acetyl-CoA. Also provided herein are non-naturally occurring eukaryotic organisms having a 1,3-butanediol (1,3-BDO) pathway. and methods of using such organisms to produce 1,3-BDO.
  • Alcohol Dehydrogenase Variants

    view source
  • US Patent:
    20160237410, Aug 18, 2016
  • Filed:
    Oct 3, 2014
  • Appl. No.:
    15/027169
  • Inventors:
    - San Diego CA, US
    Michael Patrick Kuchinskas - San Diego CA, US
    Jingyi Li - San Diego CA, US
    Harish Nagarajan - San Diego CA, US
    Priti Pharkya - San Diego CA, US
  • International Classification:
    C12N 9/04
    C12P 7/24
  • Abstract:
    Described herein are non-natural NAD+-dependent alcohol dehydrogenases (ADHs) capable of at least two fold greater conversion of methanol or ethanol to formaldehyde or acetaldehyde, respectively, as compared to its unmodified counterpart. Nucleic acids encoding the non-natural alcohol dehydrogenases, as well as expression constructs including the nucleic acids, and engineered cells comprising the nucleic acids or expression constructs are described. Also described are engineered cells expressing a non-natural NAD-dependent alcohol dehydrogenase, optionally include one or more additional metabolic pathway transgene(s), methanol metabolic pathway genes, target product pathway genes, cell culture compositions including the cells, methods for promoting production of the target product or intermediate thereof from the cells, compositions including the target product or intermediate, and products made from the target product or intermediate.

Medicine Doctors

Jingyi Li Photo 6

Jingyi Li

view source

Googleplus

Jingyi Li Photo 7

Jingyi Li

Jingyi Li Photo 8

Jingyi Li

Jingyi Li Photo 9

Jingyi Li

Jingyi Li Photo 10

Jingyi Li

Jingyi Li Photo 11

Jingyi Li

Jingyi Li Photo 12

Jingyi Li

Jingyi Li Photo 13

Jingyi Li

Jingyi Li Photo 14

Jingyi Li

Facebook

Jingyi Li Photo 15

Jingyi Li

view source
Jingyi Li Photo 16

Jingyi Li

view source
Jingyi Li Photo 17

Jingyi Li

view source
Jingyi Li Photo 18

Jingyi Li

view source
Jingyi Li Photo 19

(Jingyi Li)

view source
Jingyi Li Photo 20

Jingyi Li

view source
Jingyi Li Photo 21

Jingyi Li

view source
Jingyi Li Photo 22

Jingyi Li

view source

Plaxo

Jingyi Li Photo 23

Li, Jingyi

view source

Youtube

LEO IU dance - Li Zhi, Nazneen & Jing Yi (Sea...

One of the dance performance that made the crowd go mad. :) Audiences ...

  • Category:
    Entertainment
  • Uploaded:
    24 Apr, 2008
  • Duration:
    6m 22s

SNH48 Ju Jingyi - Li Bie De Che Zhan (Vicki Z...

  • Duration:
    5m 51s

Jessica (Jingyi) Li "Statistical Methods for ...

Tuesday July 17, 2018 UCLA Faculty Center, California Room Computation...

  • Duration:
    45m 29s

Portfolio videos by Jingyi Li

  • Duration:
    2m 27s

Towards Balancing Real-World Awareness and VR...

Towards Balancing Real-World Awareness and VR Immersion in Mobile VR J...

  • Duration:
    3m 4s

Jingyi Li, Immersive/Intera... Environment P...

I used unity to make these 7 interactive rooms, each with different sy...

  • Duration:
    2m 50s

Flickr


Get Report for Jingyi Li from Carlsbad, CA, age ~53
Control profile